Straits Times Index
3,300.19 +7.50 (+0.23%) Nikkei
38,279.80 +5.75 (+0.02%) Hang Seng
18,153.54 +390.51 (+2.20%) FTSE 100
8,121.24 -22.89 (-0.28%) Bitcoin USD
57,460.27 -2,750.43 (-4.57%) CMC Crypto 200
1,261.51 -77.56 (-5.79%)
Vaxcyte, Inc. (PCVX)
After hours:
- GlobeNewswire
Vaxcyte to Present at the 23rd Annual Needham Virtual Healthcare Conference
SAN CARLOS, Calif., April 02, 2024 (GLOBE NEWSWIRE) -- Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases, announced today that Company management will participate in a fireside chat at the 23rd Annual Needham Virtual Healthcare Conference on Tuesday, April 9 at 12:45 p.m. ET / 9:45 a.m. PT. A live webcast of the fireside chat can be accessed through the Investors & Media se
- GuruFocus.com
Sutro Biopharma Inc (STRO) Earnings: A Mixed Bag Amidst Strategic Advances
Full Year Earnings Reveal Strong Revenue Growth but Operational Challenges Persist
- GuruFocus.com
Insider Sell: Vaxcyte Inc (PCVX) CFO Andrew Guggenhime Sells 8,000 Shares
Andrew Guggenhime, President and Chief Financial Officer of Vaxcyte Inc (NASDAQ:PCVX), has sold 8,000 shares of the company on March 18, 2024, according to a recent SEC filing.
